Blog

Jul 28, 2018

A Major Drug Company Now Has Access to 23andMe’s Genetic Data. Should You Be Concerned?

Posted by in categories: biotech/medical, genetics, privacy

Consumer genetic testing company 23andMe announced on Wednesday that GlaxoSmithKline purchased a $300 million stake in the company, allowing the pharmaceutical giant to use 23andMe’s trove of genetic data to develop new drugs — and raising new privacy concerns for consumers.


23andMe is partnering with big pharma company GlaxoSmithKline. Here’s what that means for consumer rights and genetic privacy.

Read more

Comments are closed.